Research Laboratories for Health Science & Food Technologies, Kirin Company, Ltd., Yokohama, Kanagawa, Japan.
Psychopharmacology (Berl). 2019 Sep;236(9):2847-2854. doi: 10.1007/s00213-019-05263-7. Epub 2019 May 8.
Cognitive decline and dementia are major concerns in today's aging society. As limited treatments are available, measures to prevent cognitive decline and dementia are needed. We previously demonstrated that matured hop bitter acids (MHBA), bitter components of beer, increase norepinephrine in the hippocampus and improve memory in amnesia model mice induced by scopolamine (SCP), an antagonist of muscarinic receptor. However, other neurotransmitters involved in the effects of MHBA on memory improvement remain unknown.
This study aimed to assess the role of acetylcholine receptors (AChR) in the effects of MHBA on memory.
The involvement of AChR on the effects of MHBA (10 mg/kg) on cognitive function was evaluated using AChR antagonists, SCP, mecamylamine hydrochloride (MEC), a non-competitive antagonist of nicotinic-AChR (nAChR), and methyllycaconitine citrate (MLA), an α7nAChR antagonist, for the Y-maze test and the novel object recognition test (NORT). A separate population of mice, which underwent vagotomy or sham operation, was subjected to NORT to elucidate further mechanism. In addition, the effect of MHBA on acetylcholinesterase (AChE) activity was measured in vitro.
In accordance with previous reports, MHBA improved spontaneous alternations of the Y-maze test in SCP-induced amnesia mice and increased discrimination index evaluated by the NORT in normal mice. On the other hand, treatment with MEC or MLA attenuated the effects of MHBA on memory improvement in the Y-maze test and the NORT. Vagotomized mice also showed attenuated memory enhancement by MHBA in the NORT. In addition, MHBA did not alter AChE activity in vitro.
The results support the involvement of nAChRs in memory improvement in mice by MHBA. MHBA is thus thought to activate the vagal nerve and enhance hippocampus-dependent memory via nAChRs.
认知能力下降和痴呆是当今老龄化社会的主要关注点。由于目前治疗方法有限,因此需要采取措施预防认知能力下降和痴呆。我们之前已经证明,成熟的啤酒花酸(MHBA),啤酒中的苦味成分,可增加海马体内的去甲肾上腺素,并改善东莨菪碱(SCP)诱导的记忆障碍模型小鼠的记忆,SCP 是毒蕈碱受体的拮抗剂。然而,其他参与 MHBA 改善记忆作用的神经递质仍不清楚。
本研究旨在评估乙酰胆碱受体(AChR)在 MHBA 对记忆影响中的作用。
使用 AChR 拮抗剂东莨菪碱、盐酸美金刚胺(MEC)、烟碱型乙酰胆碱受体(nAChR)非竞争性拮抗剂和α7nAChR 拮抗剂柠檬酸甲基金刚烷(MLA)评估 MHBA(10mg/kg)对认知功能的影响,用于 Y 迷宫测试和新颖物体识别测试(NORT)。另一组接受迷走神经切断术或假手术的小鼠进行 NORT,以进一步阐明其机制。此外,还在体外测量 MHBA 对乙酰胆碱酯酶(AChE)活性的影响。
与之前的报告一致,MHBA 改善了 SCP 诱导的记忆障碍小鼠的 Y 迷宫测试中的自发交替,并增加了正常小鼠的 NORT 评估的辨别指数。另一方面,MEC 或 MLA 的治疗减弱了 MHBA 在 Y 迷宫测试和 NORT 中对记忆改善的作用。NORT 中 MHBA 也减弱了迷走神经切断术小鼠的记忆增强。此外,MHBA 不会改变体外的 AChE 活性。
这些结果支持 MHBA 通过 nAChR 参与小鼠的记忆改善。因此,MHBA 被认为通过 nAChR 激活迷走神经并增强海马依赖性记忆。